Severin Schwan | Swiss Economic Forum 2026
Severin Schwan at the Swiss Economic Forum (SEF) 2026.
Chairman of the Board of Directors, Roche Holding
Verified interview transcripts, podcast appearances, and direct quotes from Severin Schwan, Chairman of the Board of Directors at Roche Holding. AI-verified speaker identity with full-text searchable transcripts.
Severin Schwan at the Swiss Economic Forum (SEF) 2026.
Dr. Severin Schwan, Roche CEO, joins 'Squawk on the Street' to discuss the company's response to Covid-19, how his business ...
Is Switzerland losing its position among the world’s leading locations for R&D? Our first Innoscape Talk is dedicated to the topic of innovation in the Swiss pharmaceutical industry. Severin Schwan (CEO Roche) explains his views about current developments in the Swiss life sciences sector and shares his experiences on how to accelerate innovation within a corporation. Questions: 00:00 Intro 00:24 How can a corporation enhance innovation activity? 02:04 Does the approach to innovation vary between different R&D locations of Roche? 05:38 What are the strengths of Switzerland as a location fo…
DIGITALIZATION & INNOVATION - SUCCESS FACTORS FOR THE FUTURE MCI Livetalk mit Severin Schwan, CEO, Roche ...
Dec.22 -- Francine Lacqua is in conversation with the Chief Executive of Roche, Severin Schwan. They talk leadership in the ...
Jul.23 -- Roche Chief Executive Officer Severin Schwan discusses Covid-19 testing, expectations for a second wave of the virus, and a potential timeline for a vaccine. He speaks with Bloomberg’s Francine Lacqua on “Bloomberg Surveillance.”
Oct.16 -- Roche Holding AG Chief Executive Officer Severin Schwan speaks on Bloomberg Television after the Basel, ...
The Roche CEO discusses his remuneration, the importance of failure, and why Switzerland risks losing its competitive edge in the field of big data.
The Basel-based pharmaceutical company Roche boasts a unique success story. Founded in 1986, the company was a leader in chemical and pharmaceutical research for many years, producing well-known medications such as Valium and Tamiflu. With the development of biotechnology, Roche has shifted its focus – today, the company is a global leader in cancer research and therapy. NZZ Editor-in-Chief Eric Gujer and political philosopher Katja Gentinetta discuss the Basel-based pharmaceutical company's success strategies, the necessity of remaining innovative, and the importance of Switzerland as a busi…
November 19, 2013 - Severin Schwan, CEO, Roche View full article here, ...
On the occasion of the balance sheet media conference for the 2015 results, Roche CEO Severin Schwan comments on the enforcement initiative and the strong franc. Link to article: www.tageswoche.ch/+o5eaz
Sign in to search the full transcript archive, filter by topic, and access every quote from Severin Schwan.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →
Pro unlocks every transcript in full, plus unlimited search across every executive and company we cover.
50% off appliedPulling data at scale? The Data API gives you 30,000 transcripts a month over REST, MCP and JSON.
Compare all plans